AstraZeneca Pharma India gets permission to import Palivizumab solution for injection
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Palivizumab (Synagis) is indicated for the prevention of serious lower respiratory tract disease requiring hospitalization caused by respiratory syncytial virus
Appointment further strengthens company’s expertise in fastest-growing therapeutic area to meet patient need
Norepinephrine Bitartrate Injection is used for restoration of blood pressure in adult patients
Approval of this product under the PEPFAR program completes Strides’ qualification to all major markets and donor programs including Global Fund and South Africa
The products will be manufactured at the company's facility in Bengaluru
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
This approval has come from the company's finished dosage form manufacturing facility
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
The approval bolsters the company's Mycophenolate Mofetil portfolio
Subscribe To Our Newsletter & Stay Updated